newsfilter
← Latest News
GlobeNewswire·

AVITA Medical to Announce First Quarter 2026 Financial Results

  • AVITA Medical, Inc. will report first quarter 2026 financial results after the close of U.S. markets on Thursday, May 14, 2026.
  • The company will host a conference call & webcast at 1:30 p.m. Pacific Time on Friday, May 15, 2026, to discuss results & business highlights.
  • Registration links are provided for both the webcast & live conference call participation.
  • A replay of the broadcast will be available on the investor relations website's events page for those unable to attend live.
  • AVITA Medical's primary technology, RECELL, is an FDA-approved Spray-On Skin solution for thermal burn & trauma wounds.
  • In the U.S., AVITA holds exclusive rights to market Cohealyx & manufacture, market, sell, & distribute PermeaDerm.
  • Internationally, RECELL is CE-marked in Europe, TGA-registered in Australia, & PMDA-approved in Japan.
  • Investor & media contact information for Ben Atkins is available for inquiries.